Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation

被引:465
作者
Kratchmarova, I
Blagoev, B
Haack-Sorensen, M
Kassem, M
Mann, M
机构
[1] Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark
[2] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
关键词
D O I
10.1126/science.1107627
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Closely related signals often lead to very different cellular outcomes. We found that the differentiation of human mesenchymal stem cells into bone-forming cells is stimulated by epidermal growth factor (EGF) but not platelet-derived growth factor (PDGF). We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF, implicating it as a possible control point. Indeed, chemical inhibition of PI3K in PDGF-stimulated cells removed the differential effect of the two growth factors, bestowing full differentiation effect onto PDGF. Thus, quantitative proteomics can directly compare entire signaling networks and discover critical differences capable of changing cell fate.
引用
收藏
页码:1472 / 1477
页数:6
相关论文
共 31 条
  • [1] Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene in despite of extensive proliferation
    Abdallah, BM
    Haack-Sorensen, M
    Burns, JS
    Elsnab, B
    Jakob, F
    Hokland, P
    Kassem, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 326 (03) : 527 - 538
  • [2] Mass spectrometry-based proteomics
    Aebersold, R
    Mann, M
    [J]. NATURE, 2003, 422 (6928) : 198 - 207
  • [3] Stem cells in tissue engineering
    Bianco, P
    Robey, PG
    [J]. NATURE, 2001, 414 (6859) : 118 - 121
  • [4] Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics
    Blagoev, B
    Ong, SE
    Kratchmarova, I
    Mann, M
    [J]. NATURE BIOTECHNOLOGY, 2004, 22 (09) : 1139 - 1145
  • [5] A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling
    Blagoev, B
    Kratchmarova, I
    Ong, SE
    Nielsen, M
    Foster, LJ
    Mann, M
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (03) : 315 - 318
  • [6] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [7] Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -β-catenin-independent signaling pathway
    Debiais, F
    Lefèvre, G
    Lemonnier, J
    Le Mée, S
    Lasmoles, F
    Mascarelli, F
    Marie, PJ
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 297 (01) : 235 - 246
  • [8] Identification of a novel inhibitor of mitogen-activated protein kinase kinase
    Favata, MF
    Horiuchi, KY
    Manos, EJ
    Daulerio, AJ
    Stradley, DA
    Feeser, WS
    Van Dyk, DE
    Pitts, WJ
    Earl, RA
    Hobbs, F
    Copeland, RA
    Magolda, RL
    Scherle, PA
    Trzaskos, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18623 - 18632
  • [9] THE PROTEIN-KINASE ENCODED BY THE AKT PROTOONCOGENE IS A TARGET OF THE PDGF-ACTIVATED PHOSPHATIDYLINOSITOL 3-KINASE
    FRANKE, TF
    YANG, SI
    CHAN, TO
    DATTA, K
    KAZLAUSKAS, A
    MORRISON, DK
    KAPLAN, DR
    TSICHLIS, PN
    [J]. CELL, 1995, 81 (05) : 727 - 736
  • [10] Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling
    Fukuyama, R
    Fujita, T
    Azuma, Y
    Hirano, A
    Nakamuta, H
    Koida, M
    Komori, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (03) : 636 - 642